United Therapeutics Equity 2024

United Therapeutics Aktienanalyse

What does United Therapeutics do?

United Therapeutics Corporation, headquartered in Silver Spring, Maryland, is a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with rare and serious diseases. The company is a pioneer in creating life-saving therapies for a variety of conditions, including pulmonary hypertension, chronic lung failure, and lung cancer. United Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing United Therapeutics's Equity

United Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding United Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating United Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

United Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in United Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about United Therapeutics Stock

What is the equity of United Therapeutics this year?

United Therapeutics has equity of 5.98 B USD this year.

What was the equity of United Therapeutics compared to the previous year?

The equity of United Therapeutics has increased/decreased by 24.77% increased compared to the previous year.

What impact does a high equity have on investors of United Therapeutics?

A high equity is advantageous for investors of United Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of United Therapeutics?

A low equity can be a risk for investors of United Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of United Therapeutics affect the company?

An increase in equity of United Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of United Therapeutics affect the company?

A reduction in equity of United Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of United Therapeutics?

Some factors that can affect the equity of United Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of United Therapeutics so important for investors?

The equity of United Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can United Therapeutics take to change the equity?

To change equity, United Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does United Therapeutics pay?

Over the past 12 months, United Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, United Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of United Therapeutics?

The current dividend yield of United Therapeutics is .

When does United Therapeutics pay dividends?

United Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of United Therapeutics?

United Therapeutics paid dividends every year for the past 0 years.

What is the dividend of United Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is United Therapeutics located?

United Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von United Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of United Therapeutics from 6/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/25/2024.

When did United Therapeutics pay the last dividend?

The last dividend was paid out on 6/25/2024.

What was the dividend of United Therapeutics in the year 2023?

In the year 2023, United Therapeutics distributed 0 USD as dividends.

In which currency does United Therapeutics pay out the dividend?

The dividends of United Therapeutics are distributed in USD.